Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
1.140
-0.010 (-0.87%)
At close: Mar 2, 2026
-65.45% (1Y)
| Market Cap | 34.65M -59.9% |
| Revenue (ttm) | 36.76M +14.2% |
| Net Income | -25.78M |
| EPS | -0.94 |
| Shares Out | 30.40M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,586 |
| Average Volume | 37,936 |
| Open | 1.110 |
| Previous Close | 1.150 |
| Day's Range | 1.100 - 1.140 |
| 52-Week Range | 0.972 - 3.500 |
| Beta | 1.18 |
| RSI | 48.47 |
| Earnings Date | Apr 15, 2026 |